In section Releases

Resonant Clinical Solutions Acquires Labfish to Bolster European Reach

Leesburg-based Resonant Clinical Solutions has acquired Germany’s Labfish, a specialized provider of laboratory equipment rentals and calibration services. The move integrates Labfish’s Hamburg-based operations into Resonant’s global supply chain framework, significantly expanding its footprint in Europe and enhancing its technical logistics capabilities for complex international clinical trials.

Resonant Clinical Solutions Acquires Labfish to Bolster European Reach

Labfish, founded in 2014, brings a substantial inventory of clinical equipment, including infusion pumps, freezers, and scales, to the Resonant portfolio. The company maintains ISO 9001 certification and operates one of the largest in-house calibration facilities for clinical research in Europe. Beyond hardware, Labfish provides critical Importer of Record and Exporter of Record services, supported by a network of partner depots spanning Argentina, Israel, Turkey, and China. This infrastructure allows the firm to facilitate shipments to clinical sites across more than 70 countries.

Christophe Berthoux, CEO of Resonant, noted that the acquisition aligns with the company’s strategy to support the full clinical trial lifecycle. For Labfish founder Martin Forster, the merger provides a platform to scale the specialized warehouse and calibration services his team developed over the past decade. While financial details remain undisclosed, the deal signals a strategic push by Resonant to meet the rising demand for white-glove logistics in an increasingly complex pharmaceutical research landscape.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!